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ABSTRACT 
The market of counterfeit medicine is slowly growing making more people to 
be exposed with these kind products. Counterfeit medicine can bring many adverse 
effects to health as well as social and economic wise. The purpose of this study is to 
investigate the content of over-the-counter (OTC) paracetamol that were sold in Johor 
Bahru area. With the growing market for substandard/spurious/falsely-
labelled/falsified/counterfeit (SSFFC) products including medicinal products, the 
statuses of these paracetamol tablets sold in market can raise some doubts. For that 
matter, generic OTC paracetamol 650 mg tablets brand A was chosen to be 
investigated. The tablets were sampled from three different type of premises namely 
convenient stores X, pharmacies and traditional medicine stores in four different 
municipal districts of Majlis Bandaraya Johor Bahru (MBJB): Pulai, Tebrau, Johor 
Bahru and Pasir Gudang. A few examinations and analyses were conducted to achieve 
this goal: a) qualitative screening examinations of product packaging (hologram and 
blister packaging) using Video Spectral Comparator (VSC) instrument to distinguish 
any SSFFC products, b) chemical profiling the ingredients of the products using 
Attenuated Total Reflectance – Fourier Transform Infrared (ATR-FTIR) spectroscopy 
to detect the presence of active pharmaceutical ingredient (API) and c) quantitative 
analysis of the amount of API using High Performance Liquid Chromatography 
coupled with Diode-Array Detector (HPLC-DAD) and the method was validated. 
Visual inspection of the packaging showed that apart from sample PGKU 2, all 
samples came from genuine source was suggested. The second screening process using 
ATR-FTIR found that all samples contained API as claimed (within the range of 95-
105%). HPLC-DAD findings showed that the content of paracetamol could be divided 
into three; 1) within the range (625.14 – 671.62 mg), 2) below the range (400.87 – 
616.73 mg) and 3) above the range (700.53 – 1147.50 mg). Based on these findings, 
each of the sample then was classified into three categories of SSFFC, that were 
substandard, unregistered/unlicensed and falsified. No sample was identified as 
unregistered/unlicensed. One sample, PGKU 2 was classified as falsified meanwhile 
the remaining samples were identified as substandard. In conclusion, the output of this 
study can be used to regulate and pharmaceutical companies and to monitor the SSFFC 
market.   
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ABSTRAK 
Pasaran bagi bahan ubatan tiruan semakin membesar dan menyebabkan lebih 
ramai orang terdedah kepada produk ini. Barangan ubatan tiruan boleh memberi 
banyak kesan buruk dari segi kesihatan serta dari segi ekonomi dan sosial. Tujuan 
kajian ini dijalankan adalah untuk menyiasat kandungan ubat atas kaunter (OTC) 
acetaminophen atau lebih dikenali umum sebagai paracetamol. Dengan 
perkembangan pasaran bagi barangan tiruan (SSFFC) yang semakin membesar 
termasuk bahan produk kesihatan telah menimbulkan keraguan dalam status 
keasliannya. Oleh demikian itu, ubat OTC generik paracetamol 650 mg jenama A 
telah disampel di tiga jenis kedai iaitu kedai serbaneka “X”, farmasi dan kedai ubat 
tradisional di empat daerah Majlis Bandaraya Johor Bahru (MBJB): Pulai, Tebrau, 
Johor Bahru dan Pasir Gudang. Beberapa pemeriksaan dan analisis telah dijalankan 
untuk mencapai matlamat kajian: a) pemeriksaan pembungkusan produk (hologram 
dan pembungkusan blister) menggunakan alat video spectral comparator (VSC), b) 
pemprofilan kimia bahan-bahan produk menggunakan spektroskopi transformasi 
Fourier inframerah (ATR-FTIR) dan c) kuantitatif analisis kandungan bahan aktif 
farmaseutikal (API) menggunakan kromatografi cecair berprestasi tinggi (HPLC-
DAD). Pemeriksaan visual pembungkusan menunjukkan semua sampel adalah asli 
selain dari sampel PGKU 2. Pemeriksaan kedua menggunakan ATR-FTIR telah 
menjumpai API seperti yang dinyatakan (dalam lingkungan 95 – 105%). Keputusan 
HPLC-DAD menunjukkan kandungan paracetamol boleh dikategorikan kepada tiga; 
1) dalam lingkungan (625.14 – 671.62 mg), 2) bawah lingkungan (400.87 – 616.73 
mg) dan 3) atas lingkungan (700.53 – 1174.50 mg). Berdasarkan keputusan semua 
analisis, setiap sampel akan diklasifikasi kepada tiga kategori; substandard, tidak 
berdaftar/tidak berlesen dan palsu. Tiada sampel yang dikenali sebagai tidak 
berdaftar/tidak berlesen. Satu sampel, PGKU 2 dikenali sebagai palsu dan selebihnya 
dikenali sebagai substandard. Kesimpulannya, keputusan yang diperoleh dari analisis 
ini dapat membantu pihak berkuasa untuk mengawal selia syarikat farmaseutikal dan 
memantau pasaran SSFFC. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
 
1.1 Problem Background 
 
One of the most common over-the-counter (OTC) medicine that can be 
obtained in Malaysia is acetaminophen or commonly known as paracetamol. It is 
often prescribed to treat fever, mild pain relief, muscular aches, migraine headache 
and osteoarthritis. A survey conducted in Penang, Malaysia showed that 75% of 
consumers used it for headache, and 72% of them used it for fever (Chong, Tan, & 
Chooi, 2017).  
 
Since paracetamol is a cheap OTC drug that is easily obtained, it is prone to 
be counterfeited. Counterfeiting medicines are a serious crime. Currently there is 
no universally accepted definition of counterfeit medicines. World Health 
Organization (WHO) is currently using the term ‘substandard/spurious/falsely-
labelled/falsified/counterfeit’ or abbreviated as SSFFC for medical products, and 
these products are categorized into three sub-groups; substandard, unregistered and 
falsified (World Health Organization). On the other hand, counterfeit medicine 
defined by U.S Food & Drug Administration (FDA) is fake medicine that may be 
contaminated or contain none or wrong active ingredient, or could have the correct 
active ingredient but at the wrong dose (U.S Food & Drug). Pharmaceutical 
Security Institute in 2011 reported that Asia has 40% pharmaceutical crime reported 
(Stevens & Mydin, 2013). According to a report by Ministry of Health (MOH) 
Malaysia, 5.2% of medicines sold over-the-counter are fake medicine (Zulkifli et 
al., 2016).  Fake medicines possess many risky problems that can affect an 
individual’s health. It may contain harmful toxic contaminants such as heavy metals 
(arsenic or lead) which are carcinogenic and toxic to human bodies (Stevens & 
Mydin, 2013). In 1995, a large number of children was admitted to hospital due to 
renal failure in Bangladesh due to paracetamol elixir containing diethylene glycol 
	 2 
(Hanif et al., 1995). The prices of fake medicines are usually lower than the standard 
pricing, hence consumers are more likely to purchase the fake medicines causing a 
substantial loss percentage for the pharmaceutical industry (Blackstone, Fuhr, & 
Pociask, 2014).  
 
Several technologies are being used to combat these problems. It includes 
as the usage of visible markers or holograms, barcodes, 2D datamatrix code and 
radiofrequency identifications (Hall, 2012). In 2005, Malaysia introduced 
Meditag™ program that requires all Drug Control Authorities (DCA) registered 
products to bear holographic security device (Zulkifli et al., 2016). On the other 
hand, several techniques have been used to determine paracetamol content in 
pharmaceutical formulations or biological samples. For examples; Fourier 
transform infrared spectroscopy (FTIR) with the result of percentage recovery 
between  98% to 99% in solid paracetamol samples (Mallah et al., 2015) and UV-
Vis spectrophotometry with percentage recovery between 101.67% to 102.43% in 
paracetamol and nabumethone combined tablet samples (Rote et al., 2012).  Altun 
(2002) performed analysis of paracetamol using high performance liquid 
chromatography (HPLC) with percentage recovery of 101.62% in a mixture of 
paracetamol, caffeine and dipyrone samples, while Calinescu et al. (2012) obtained 
recovery results in the range 99.6% to 102.8% in paracetamol and its impurities 
samples using the same instrument.  
This present study, a few examinations were conducted to investigate the 
status of OTC paracetamol tablets Brand A that were sold in four municipal districts 
of Majlis Bandaraya Johor Bahru (MBJB); Pulai, Tebrau, Johor Bahru and Pasir 
Gudang. With the ever-growing population people living in MBJB areas, more 
people are exposed with the risk of getting SSFFC products on their hands. 
 
 
 
1.2 Problem Statement 
 
Amount of SSFFC medical products are on the rise on the market despite 
many efforts being done by the authorities to combat it. Falsified or substandard 
medicines can bring many adverse health effects towards its consumers, as well as 
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economic effects (Aminu & Gwarzo, 2017; Burki, 2010; Newton et al., 2010). Due 
to its lower prices as compared to its genuine products, the public tend to choose 
the fake instead (Dégardin et al., 2014). Lacked information on qualitative and 
quantitative analyses regarding these SSFFC medicines making the public to be less 
aware of these rising problems. Up until 2018, there is no study have been done on 
the status of Brand A whether in Johor Bahru or Malaysia. This study will help to 
provide more information on the status of paracetamol tablets and to bring more 
awareness towards the public. 
 
 
 
1.3 Research Goals 
 
1.3.1 Research Objectives 
 
 The aim of the study is to investigate on the content of over the counter 
(OTC) paracetamol that were sold in Johor Bahru, Malaysia. The objectives of the 
research are: 
 
(a) To qualitatively screen packaging and the tablet of paracetamol 650 mg 
Brand A using Video Spectral Comparator instrument for distinguishing 
any possible SSFFC products 
 
(b) To qualitatively screen the active and non-active ingredients of paracetamol 
650 mg Brand A by using Attenuated Total Reflectance – Fourier 
Transform Infrared Spectroscopy instrument. 
 
(c) To quantitatively determine the amount of active ingredient 
(acetaminophen) in paracetamol 650 mg Brand A using High Performance 
Liquid Chromatography coupled with Diode-Array Detector. 
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1.4  Scopes of study 
  
This present research is involving paracetamol 650 mg tablet brand A 
acquired from different type of premises namely convenient stores X, pharmacies 
and traditional medicine stores. Four municipal districts of MBJB were chosen as 
sampling locations. This study was conducted from September until December 
2018. Regardless multiple contacts were made concerning getting direct samples 
manufacturers of paracetamol 650 mg Brand A, no response was given. Screening 
of the sample packaging was done using Video Spectral Comparator (VSC) to 
check for its authenticity. Chemical profiling of the sample was also done using 
Attenuated Total Reflectance – Fourier Transform Infrared Spectroscopy (ATR-
FTIR). Paracetamol content in the sample also was analyzed and quantitated by 
using High Performance Liquid Chromatography coupled with Diode-Array 
Detector (HPLC-DAD). At the end of this study, the samples were classified into 
three different categories as described by World Health Organization (WHO); 
substandard, unregistered/unlicensed and falsified. 
 
 
 
1.5  Significance of study 
 
Findings that were obtained from this study can be used as a useful data for 
related authorities to regulate pharmaceutical companies and manufacturers to meet 
the quality and standards that have been set up. The data also can be used by the 
authorities to monitor the counterfeit market of medicinal products. 
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